Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives $1 Million from New Partnership with Altria to Fund DehydraTECH R&D
LXRP’s subsidiary, Lexaria Nicotine LLC, enters definitive investment agreement with Altria Ventures Inc.; Altria to fund R&D, receive license rights and equity Altria will fund research on LXRP’s DehydraTECH oral nicotine products, pay sales royalties and may fund up to $12 million more through a series of private financings LXRP has not sold or optioned its own equity and still retains majority equity ownership of Lexaria Nicotine, LLC; Altria would receive minority equity interest in the subsidiary Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) wholly owned subsidiary, Lexaria Nicotine LLC, has entered a definitive investment agreement with Altria Group Inc.’s…